Scinovex
article Open AccessTop 1% cited

Changes in circulating microRNA levels associated with prostate cancer

British Journal of Cancer · 2012 · Vol. 106(4) · pp. 768–774
Richard J. BryantTraci PawlowskiJames W.F. CattoGemma MarsdenR L VessellaBrian RheesChristine KuslichTapio VisakorpiFreddie C. Hamdy

Abstract

These observations suggest that changes in miR concentration in prostate cancer patients may be identified by analysing various body fluids. Moreover, circulating miRs may be used to diagnose and stage prostate cancer.

Extracellular vesicles in diseaseMicroRNA in disease regulationCircular RNAs in diseasesProstate cancermicroRNAProstateCancerMedicineOncologyCancer researchInternal medicineBiologyBioinformatics

MeSH terms

AgedHumansMaleNeoplasm MetastasisPrognosisProstatic NeoplasmsBiomarkers, TumorProstate-Specific AntigenMicroRNAs

Funding

  • Cancer Research Institute
  • National Cancer Research Institute
  • National Institute for Health and Care Research
  • University of Oxford
  • European Commission
  • National Institutes of Health
Citations
710
FWCI
29.93
field-weighted impact
References
16
Percentile
100%
vs. same field & year
Citations per year
References
Causes and consequences of microRNA dysregulation in cancer
Nature Reviews Genetics · 2009 · 3,006 citations
The MicroRNA Spectrum in 12 Body Fluids
Clinical Chemistry · 2010 · 2,706 citations
Circulating microRNAs as stable blood-based markers for cancer detection
Proceedings of the National Academy of Sciences · 2008 · 7,894 citations
Cancer Statistics, 2010
CA A Cancer Journal for Clinicians · 2010 · 12,602 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Changes in circulating microRNA levels associated with prostate cancer · Scinovex